Variant report
Variant | esv2756053 |
---|---|
Chromosome Location | chr7:3910039-3920129 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs191388391 | chr7:3910051-3910052 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372286463 | chr7:3910056-3910057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182807949 | chr7:3910064-3910065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540529452 | chr7:3910065-3910066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560230271 | chr7:3910086-3910087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs112300507 | chr7:3910087-3910088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs75285862 | chr7:3910107-3910108 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs376795977 | chr7:3910110-3910111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10251587 | chr7:3910201-3910202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs78528915 | chr7:3910202-3910203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs537284011 | chr7:3910239-3910240 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs528575993 | chr7:3910251-3910252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6977844 | chr7:3910257-3910258 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs190681714 | chr7:3910267-3910268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs550718226 | chr7:3910286-3910287 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs570709387 | chr7:3910299-3910300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs111419428 | chr7:3910314-3910315 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs182356415 | chr7:3910318-3910319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs141969761 | chr7:3910320-3910321 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs566884281 | chr7:3910339-3910340 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs535450705 | chr7:3910359-3910360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs112713289 | chr7:3910387-3910388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371530413 | chr7:3910402-3910403 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs10226220 | chr7:3910406-3910407 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs538040940 | chr7:3910425-3910426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs558031280 | chr7:3910431-3910432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs577902581 | chr7:3910443-3910444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs10244636 | chr7:3910490-3910491 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs145718572 | chr7:3910491-3910492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573599062 | chr7:3910513-3910514 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs112340753 | chr7:3910530-3910531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs187840129 | chr7:3910536-3910537 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531352748 | chr7:3910543-3910544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs544698187 | chr7:3910544-3910545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs564376487 | chr7:3910591-3910592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116253188 | chr7:3910628-3910629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs546908787 | chr7:3910634-3910635 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs567016934 | chr7:3910637-3910638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192600009 | chr7:3910650-3910651 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs6961561 | chr7:3910657-3910658 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
41 | rs569229671 | chr7:3910663-3910664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs78130307 | chr7:3910667-3910668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538383169 | chr7:3910676-3910677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558266632 | chr7:3910680-3910681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs77306795 | chr7:3910691-3910692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs368027251 | chr7:3910733-3910734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12690803 | chr7:3910750-3910751 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs554045556 | chr7:3910755-3910756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200291112 | chr7:3910783-3910784 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs148901334 | chr7:3910804-3910805 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Chordoma | 21602918 | CNVD |
Lynch syndrome | 22585707 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Breast cancer | 16397240 | CNVD |
Raine Syndrome | 17924334 | CNVD |
Diffuse large b-cell lymphoma | 21266526 | CNVD |
Melanoma | 18172304 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Glioma | 18556773 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Biliary cancer | 19435499 | CNVD |
Cancer | 16751803 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Wilms tumour | 21544195 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Glioma | 21971842 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Oral cancer | 21386901 | CNVD |
colon cancer | 17210682 | CNVD |
Lung adenocarcinoma | 21810691 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Hypothalamic hamartomas | 18252217 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Stenocardia | 21860640 | CNVD |
Vasospasm | 21860640 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Leukemia | 23979775 | CNVD |
Spondylocostal dysostosis | 21085971 | CNVD |
Mental retardation | 17901693 | CNVD |
Heart disease | 21282601 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Intellectual disability | 21811512 | CNVD |
Breast cancer | 22522925 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:3901200-3959600 | Weak transcription | Pancreas | Pancrea |
2 | chr7:3906800-3949000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
3 | chr7:3909200-3914000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr7:3914000-3914200 | ZNF genes & repeats | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr7:3914200-3923800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
6 | chr7:3918800-3919200 | Enhancers | Duodenum Mucosa | Duodenum |
7 | chr7:3918800-3920000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr7:3918800-3920600 | Enhancers | Fetal Brain Male | brain |
9 | chr7:3919000-3919400 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
10 | chr7:3919000-3920000 | Enhancers | Fetal Brain Female | brain |
11 | chr7:3919000-3920200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
12 | chr7:3919000-3920200 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
13 | chr7:3919000-3920200 | Enhancers | Fetal Stomach | stomach |
14 | chr7:3919000-3920600 | Enhancers | Fetal Lung | lung |
15 | chr7:3919000-3920600 | Enhancers | Fetal Muscle Leg | muscle |
16 | chr7:3919200-3919600 | Flanking Active TSS | Duodenum Mucosa | Duodenum |
17 | chr7:3919200-3919800 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
18 | chr7:3919200-3919800 | Enhancers | Fetal Heart | heart |
19 | chr7:3919200-3919800 | Enhancers | K562 | blood |
20 | chr7:3919400-3919800 | Enhancers | Brain Germinal Matrix | brain |
21 | chr7:3919400-3920000 | Enhancers | Stomach Mucosa | stomach |
22 | chr7:3919600-3920400 | Enhancers | Duodenum Mucosa | Duodenum |
23 | chr7:3919800-3920200 | Enhancers | Gastric | stomach |
24 | chr7:3919800-3924000 | Weak transcription | Fetal Heart | heart |